Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Total lesion glycolysis determined per RECIST 1.1 criteria predicts survival in EGFR mutation-negative patients with advanced lung adenocarcinoma.

Clinical nuclear medicine - 1 Jun 2015

Ho Tsung-Ying, Chou Pai-Chien, Yang Cheng-Ta, Tsang Ngan-Ming, Yen Tzu-Chen

Abstract excerpt

OBJECTIVE: The aim of this retrospective study was to investigate the clinical impact of F-FDG PET in patients with advanced lung adenocarcinoma stratified according to the epidermal growth factor receptor (EGFR) mutation status. PATIENTS AND METHODS: A total of 56 patients with advanced lung adenocarcinoma were included in the study. Thirty-one patients (55%) were EGFR mutation-positive, whereas the remaining 25...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Adenocarcinoma of Lung

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to ErbB Receptors

Share to Fluorodeoxyglucose F18

Share to Glycolysis

Share to Lung Neoplasms

Share to Positron-Emission Tomography

Share to Radiopharmaceuticals

Source

Identifiers

PMID: 25783515
DOI: 10.1097/RLU.0000000000000774

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Total lesion glycolysis determined per RECIST 1.1 criteria predicts survival in EGFR mutation-negative patients with advanced lung adenocarcinoma.PMID 25783515Read ↗

Prognostic Value of Baseline 18F-FDG PET/CT Functional Parameters in Patients with Advanced Lung Adenocarcinoma Stratified by EGFR Mutation Status.Semantic proximity Read ↗

Total Lesion Glycolysis in Positron Emission Tomography Can Predict Gefitinib Outcomes in Non-Small-Cell Lung Cancer with Activating EGFR Mutation.Semantic proximity Read ↗

Primary metabolic tumor volume from 18F-FDG PET/CT associated with epidermal growth factor receptor mutation in lung adenocarcinoma patients.Semantic proximity Read ↗

Volumetric PET parameters can predict overall survival in advanced lung adenocarcinoma.Semantic proximity Read ↗

[Evaluate the value of (18)F-FDG PET-CT imaging in predicting the mutationsin epidermal growth factor receptor in lung adenocarcinoma].Semantic proximity Read ↗

Predicting the Presence of Targetable Molecular Alteration(s) With Clinico-metabolic 18F-FDG PET Radiomics in Non-Asian Lung Adenocarcinoma Patients.Semantic proximity Read ↗

Prognostic significance of integrating total metabolic tumor volume and EGFR mutation status in patients with lung adenocarcinoma.Semantic proximity Read ↗

Prognostic and Predictive Value of 18F-FDG PET/CT Metabolic Parameters in EGFR-Mutant Lung Adenocarcinoma Treated with Tyrosine Kinase Inhibitors: A Single-Center Retrospective Study with Subgroup Analysis of 19del vs. L858RSemantic proximity Read ↗

Relation of EGFR Mutation Status to Metabolic Activity in Localized Lung Adenocarcinoma and Its Influence on the Use of FDG PET/CT Parameters in Prognosis.Semantic proximity Read ↗

[Semiquantitative parameters of 18F-FDG PET/CT, gene mutation states of epidermal growth factor receptor and anaplastic lymphoma kinase in prognosis evaluation of patients with lung adenocarcinoma].Semantic proximity Read ↗

The prognostic value of CT radiomic features for patients with pulmonary adenocarcinoma treated with EGFR tyrosine kinase inhibitors.Semantic proximity Read ↗

Incorporating radiomic feature of pretreatment 18F-FDG PET improves survival stratification in patients with EGFR-mutated lung adenocarcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.